aspirin, 150 mg/day
DISEASE INTERVENTION COMPARISON RESULTS
N Engl J Med. 2017 Jun 28. doi: 10.1056/NEJMoa1704559. [Epub ahead of print] Randomized Controlled Trial, Multicenter Study
IN preeclampsia The Use of
aspirin, 150 mg/day
As Treatment, Chronic
Is better Than
placebo
To reduce delivery with preeclampsia before 37 weeks of gestation: 1.6% aspirin VS. 4.3% placebo. No differences in the incidence of neonatal adverse outcomes.